These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9704868)
41. Neuroendocrine challenge tests: assessment of 5-HT function in anxiety and depression. Power AC; Cowen PJ Mol Aspects Med; 1992; 13(3):205-20. PubMed ID: 1435104 [No Abstract] [Full Text] [Related]
42. Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Murphy DL; Mueller EA; Hill JL; Tolliver TJ; Jacobsen FM Psychopharmacology (Berl); 1989; 98(2):275-82. PubMed ID: 2502799 [TBL] [Abstract][Full Text] [Related]
43. Neurobiology of obsessive compulsive disorder: a possible role for serotonin. Winslow JT; Insel TR J Clin Psychiatry; 1990 Aug; 51 Suppl():27-31; discussion 55-8. PubMed ID: 2199432 [TBL] [Abstract][Full Text] [Related]
44. Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controls. Garcia-Borreguero D; Jacobsen FM; Murphy DL; Joseph-Vanderpool JR; Chiara A; Rosenthal NE Biol Psychiatry; 1995 May; 37(10):740-9. PubMed ID: 7640329 [TBL] [Abstract][Full Text] [Related]
45. Do autistic traits play a role in the bullying of obsessive-compulsive disorder and social phobia sufferers? Bejerot S; Mörtberg E Psychopathology; 2009; 42(3):170-6. PubMed ID: 19276643 [TBL] [Abstract][Full Text] [Related]
46. Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects. Benjamin J; Greenberg BD; Murphy DL Psychopharmacology (Berl); 1996 Sep; 127(2):140-9. PubMed ID: 8888380 [TBL] [Abstract][Full Text] [Related]
47. Hormonal responses to meta-chlorophenylpiperazine (m-CPP) are undiminished by acute m-CPP pretreatment. Coccaro EF; Kavoussi RJ; Trestman RL; Gabriel SM; Cooper TB; Siever LJ Psychiatry Res; 1996 May; 62(2):139-45. PubMed ID: 8771611 [TBL] [Abstract][Full Text] [Related]
48. Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval. Nappi RE; Sances G; Brundu B; De Taddei S; Sommacal A; Ghiotto N; Polatti F; Nappi G Hum Reprod; 2005 Dec; 20(12):3423-8. PubMed ID: 16123089 [TBL] [Abstract][Full Text] [Related]
49. Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia. Tancer ME; Mailman RB; Stein MB; Mason GA; Carson SW; Golden RN Anxiety; 1994-1995; 1(5):216-23. PubMed ID: 9160577 [TBL] [Abstract][Full Text] [Related]
50. Serotonin dysregulation in adolescents with major depression: hormone response to meta-chlorophenylpiperazine (mCPP) infusion. Ghaziuddin N; King CA; Welch KB; Zaccagnini J; Weidmer-Mikhail E; Mellow AM; Ghaziuddin M; Greden JF Psychiatry Res; 2000 Sep; 95(3):183-94. PubMed ID: 10974357 [TBL] [Abstract][Full Text] [Related]
52. Neuroendocrine responses to single doses of buspirone in obsessive-compulsive disorder. Norman TR; Apostolopoulos M; Burrows GD; Judd FK Int Clin Psychopharmacol; 1994; 9(2):89-94. PubMed ID: 8056999 [TBL] [Abstract][Full Text] [Related]
53. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Charney DS; Woods SW; Goodman WK; Heninger GR Psychopharmacology (Berl); 1987; 92(1):14-24. PubMed ID: 3110824 [TBL] [Abstract][Full Text] [Related]
54. Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners. Broocks A; Meyer T; George A; Hillmer-Vogel U; Meyer D; Bandelow B; Hajak G; Bartmann U; Gleiter CH; Rüther E Neuropsychopharmacology; 1999 Feb; 20(2):150-61. PubMed ID: 9885795 [TBL] [Abstract][Full Text] [Related]
55. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Moss HB; Yao JK; Panzak GL Biol Psychiatry; 1990 Aug; 28(4):325-38. PubMed ID: 2397249 [TBL] [Abstract][Full Text] [Related]
56. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder. Hollander E; DeCaria C; Gully R; Nitescu A; Suckow RF; Gorman JM; Klein DF; Liebowitz MR Psychiatry Res; 1991 Jan; 36(1):1-17. PubMed ID: 2017519 [TBL] [Abstract][Full Text] [Related]
57. Studies of serotonin function in anorexia nervosa. Brewerton TD; Jimerson DC Psychiatry Res; 1996 Apr; 62(1):31-42. PubMed ID: 8739113 [TBL] [Abstract][Full Text] [Related]
58. Neuroendocrine responses to serotonergic agonists as indices of the functional status of central serotonin neurotransmission in humans: a preliminary comparative analysis of neuroendocrine endpoints versus other endpoint measures. Murphy DL; Aulakh C; Mazzola-Pomietto P; Briggs NC Behav Brain Res; 1996; 73(1-2):209-14. PubMed ID: 8788504 [TBL] [Abstract][Full Text] [Related]
59. Acute hormonal changes after IV citalopram and treatment response in OCD. Corregiari FM; Gattaz WF; Bernik M Psychopharmacology (Berl); 2007 Sep; 193(4):487-94. PubMed ID: 17492272 [TBL] [Abstract][Full Text] [Related]
60. Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus. Nappi RE; Sances G; Brundu B; Ghiotto N; Detaddei S; Biancardi C; Polatti F; Nappi G Neuroendocrinology; 2003 Jul; 78(1):52-60. PubMed ID: 12869800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]